Clinical Microbiology and Infection
Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China
Publication date: February 2022Source: Clinical Microbiology and Infection, Volume 28, Issue 2Author(s): Zonglin Dai, Irene O.L. Wong, Chan Xie, Wenxiong Xu, Yu Xiang, Liang Peng, Eric H.Y. Lau